Literature DB >> 11720890

Serum measurement of osteoprotegerin--clinical relevance and potential applications.

L C Hofbauer1, M Schoppet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11720890     DOI： 10.1530/eje.0.1450681

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  10 in total

1.  Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.

Authors:  Alessandra Colombini; Giovanni Lombardi; Emanuela Galliera; Giada Dogliotti; Pietro Randelli; Alexander Meerssemann; Giuseppe Mineo; Paolo Cabitza; Massimiliano Marco Corsi
Journal:  Int Orthop       Date:  2010-07-11       Impact factor: 3.075

2.  Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia.

Authors:  Marta Mydlárová Blaščáková; Ľudmila Blaščáková; Janka Poráčová; Jozef Mydlár; Janka Vašková; Jarmila Bernasovská; Iveta Boroňová; Eva Petrejčíková; Ivan Bernasovský
Journal:  J Clin Lab Anal       Date:  2016-11-15       Impact factor: 2.352

Review 3.  Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help?

Authors:  Doris Wagner; Astrid Fahrleitner-Pammer
Journal:  Wien Med Wochenschr       Date:  2010-08-16

4.  Multiparameter Analysis of Off-Target Effects of Dasatinib on Bone Homeostasis in Patients With Newly Diagnosed Chronic Myelogenous Leukemia.

Authors:  Daniela Hoehn; Jorge E Cortes; L Jeffrey Medeiros; Elias J Jabbour; Juliana E Hidalgo; Rashmi Kanagal-Shamanna; Carlos E Bueso-Ramos
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-08

5.  Alteration of plasma concentrations of OPG before and after levothyroxine replacement therapy in hypothyroid patients.

Authors:  X Guang-Da; S Hui-Ling; C Zhi-Song; Z Lin-Shuang
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

6.  Serum levels of the bone turnover markers dickkopf-1, osteoprotegerin, and TNF-α in knee osteoarthritis patients.

Authors:  Sicong Min; Chao Wang; Wanli Lu; Zhihong Xu; Dongquan Shi; Dongyang Chen; Huajian Teng; Qing Jiang
Journal:  Clin Rheumatol       Date:  2017-07-04       Impact factor: 2.980

7.  Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients.

Authors:  N Franchimont; C Reenaers; C Lambert; J Belaiche; V Bours; M Malaise; P Delvenne; E Louis
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

8.  The Effect of Orthognathic Surgery on Osteoprotegerin as Immunological Caliper of Bone Healing.

Authors:  Sara Soliman; Mamdouh Ahmed
Journal:  Open Access Maced J Med Sci       Date:  2016-11-22

9.  RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening.

Authors:  Max J Friedrich; Matthias D Wimmer; Jan Schmolders; Andreas C Strauss; Milena M Ploeger; Hendrik Kohlhof; Dieter C Wirtz; Sascha Gravius; Thomas M Randau
Journal:  World J Orthop       Date:  2017-04-18

10.  Increased serum OPG in atrophic nonunion shaft fractures.

Authors:  Daniele Marchelli; Luca P Piodi; Costantino Corradini; Luca Parravicini; Cesare Verdoia; Fabio M Ulivieri
Journal:  J Orthop Traumatol       Date:  2009-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.